Article
Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer.
Genetics and molecular research : GMR - 27 Oct 2014
Liu L, Li C H, Jin T F, Xu D Y
Abstract excerpt
We conducted a cohort study to investigate the role of 2 single-nucleotide polymorphisms of the excision repair cross-complimentary group 1 (ERCC1) gene polymorphism in response to chemotherapy and clinical outcomes of gastric cancer. A total of 231 patients with newly diagnosed and histopathologically confirmed primary gastric cancer participated in the study. ERCC1 rs11615 and rs3212986 were genotyped....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
